Used as a key intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the development of selective COX-2 inhibitors. Its structure supports enhanced metabolic stability and binding affinity to target enzymes. Also employed in the preparation of fluorinated organic compounds for pharmaceuticals and agrochemicals due to the electron-withdrawing effect of the trifluoromethyl group, which improves bioavailability and lipophilicity. Commonly utilized in research settings for developing new anti-cancer agents and in medicinal chemistry for structure-activity relationship (SAR) studies.